<p>Fortrea Holdings（納斯達克股票代碼：FTRE）在過去三個月內被 7 位分析師進行了分析，顯示出從看漲到看跌的多樣化觀點。</p>
<p>下表提供了他們最近評級的簡要概覽，展示了過去 30 天情緒的變化，並與前幾個月進行了比較。</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>看漲</strong></th>
<th align="right"><strong>稍微看漲</strong></th>
<th align="right"><strong>無所謂</strong></th>
<th align="right"><strong>稍微看跌</strong></th>
<th align="right"><strong>看跌</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>總評級</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>過去 30 天</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1 個月前</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2 個月前</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3 個月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>分析師們提供了更深入的見解，設定了 12 個月的價格目標，顯示出平均目標為 17.29 美元，最高預估為 25.00 美元，最低預估為 10.00 美元。當前平均價格目標超過了之前的 10.57 美元，增長了 63.58%。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769112083_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="價格目標圖表" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769112083_0.png"/></p>
<h2>分析師評級調查：詳盡研究</h2>
<p>通過對最近分析師行動的全面分析，清晰描繪了 Fortrea Holdings 在金融專家中的認知。以下總結了主要分析師、他們的最新評估以及對評級和價格目標的調整。</p>
<table>
<thead>
<tr>
<th>分析師</th>
<th>分析師公司</th>
<th>採取的行動</th>
<th>評級</th>
<th>當前價格目標</th>
<th>之前價格目標</th>
</tr>
</thead>
<tbody>
<tr>
<td>Charles Rhyee</td>
<td>TD Cowen</td>
<td>上調</td>
<td>持有</td>
<td>$15.00</td>
<td>$7.00</td>
</tr>
<tr>
<td>Jailendra Singh</td>
<td>Truist Securities</td>
<td>上調</td>
<td>買入</td>
<td>$22.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Elizabeth Anderson</td>
<td>Evercore ISI Group</td>
<td>上調</td>
<td>超越大盤</td>
<td>$25.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Ann Hynes</td>
<td>Mizuho</td>
<td>上調</td>
<td>中立</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>上調</td>
<td>等權重</td>
<td>$15.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Patrick Donnelly</td>
<td>Citigroup</td>
<td>上調</td>
<td>買入</td>
<td>$21.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>上調</td>
<td>低於權重</td>
<td>$10.00</td>
<td>$8.00</td>
</tr>
</tbody>
</table>
<h3>關鍵見解：</h3>
<ul>
<li><strong>採取的行動：</strong> 分析師根據市場條件和公司表現調整他們的建議。無論是 ‘維持’、‘上調’ 還是 ‘下調’ 他們的立場，反映了他們對 Fortrea Holdings 近期發展的反應。這些信息提供了分析師對公司當前狀態的看法快照。</li>
<li><strong>評級：</strong> 分析師提供了全面的分析，給出定性評估，從 ‘超越大盤’ 到 ‘低於大盤’。這些評級反映了對 Fortrea Holdings 相對於更廣泛市場表現的預期。</li>
<li><strong>價格目標：</strong> 理解預測，分析師提供了對 Fortrea Holdings 未來價值的估計。檢查當前和之前的目標提供了分析師預期變化的見解。</li>
</ul>
<p>將這些分析師評估與其他財務指標結合考慮，可以提供對 Fortrea Holdings 市場地位的全面理解。保持信息靈通，做出明智的決策，參考我們的評級表。</p>
<p>隨時瞭解 Fortrea Holdings 的分析師評級。</p>
<p>如果您對跟蹤小型股新聞和表現感興趣，您可以從這裏開始跟蹤。</p>
<h2>關於 Fortrea Holdings</h2>
<p>Fortrea 是一家全球性的晚期合同研究組織，提供從第一階段到第四階段的臨牀試驗管理、臨牀藥理學和患者接入解決方案。該公司與新興和大型生物製藥、醫療設備和診斷公司合作，作為功能服務提供商、全方位服務提供商進行臨牀試驗，並提供混合試驗。2023 年，Fortrea 作為一家獨立的上市公司成立，此前 Labcorp 將其臨牀開發業務剝離，該業務是通過 2015 年以 61 億美元收購 Covance 而獲得的。Fortrea 在 90 個國家擁有 19,000 名員工。</p>
<h3>Fortrea Holdings 的經濟影響：分析</h3>
<p><strong>市值分析：</strong> 該公司的市值低於行業平均水平，表明其相對於同行較小。這可能由於多種因素，包括被認為的增長潛力或運營規模。</p>
<p><strong>收入增長：</strong> 在過去的 3 個月中，Fortrea Holdings 表現積極，截至 2025 年 9 月 30 日，其收入增長率為 <strong>3.91%</strong>。這反映了公司營業收入的顯著增加。與醫療保健行業的其他公司相比，該公司面臨挑戰，增長率低於同行的平均水平。</p>
<p><strong>淨利潤率：</strong> Fortrea Holdings 的淨利潤率超過行業標準，突顯了公司的卓越財務表現。其淨利潤率為 <strong>-2.27%</strong>，公司有效管理成本，實現了強勁的盈利能力。</p>
<p><strong>股本回報率（ROE）：</strong> Fortrea Holdings 的 ROE 低於行業平均水平，表明在有效利用股本方面面臨挑戰。其 ROE 為 <strong>-2.72%</strong>，公司可能在為股東創造最佳回報方面面臨困難。</p>
<p><strong>資產回報率（ROA）：</strong> Fortrea Holdings 的 ROA 低於行業平均水平，表明在有效利用資產方面可能面臨挑戰。其 ROA 為 <strong>-0.57%</strong>，公司可能在實現最佳財務回報方面面臨困難。</p>
<p><strong>債務管理：</strong> Fortrea Holdings 的債務與股本比率為 <strong>2.04</strong>，面臨有效管理債務水平的挑戰，表明潛在的財務壓力。</p>
<h2>理解分析師評級的相關性</h2>
<p>分析師是銀行和金融系統中的專業人士，通常針對特定股票或定義的行業進行報告。這些人研究公司的財務報表，參加電話會議和會議，並與相關內部人士交談，以確定股票的分析師評級。通常，分析師每季度會對每隻股票進行評級。</p>
<p>一些分析師會發布他們對增長預估、收益和收入等指標的預測，以提供額外的評級指導。在使用分析師評級時，重要的是要記住，股票和行業分析師也是人，他們只是向投資者提供自己的意見。</p>
<p>本文由 Benzinga 的自動內容引擎生成，並經過編輯審核。</p>

<p>Fortrea Holdings（納斯達克代碼：FTRE）在過去三個月內獲得了 7 位分析師的褒貶不一的評級，12 個月的平均目標價為 17.29 美元，比之前的目標上漲了 63.58%。分析師們提高了他們的評級，其中 TD Cowen 和 Truist Securities 等公司的增幅尤為顯著。儘管 Fortrea 的收入增長率為 3.91%，但其市值低於行業平均水平，並面臨着 2.04 的高負債權益比以及負的股本和資產回報率等挑戰。分析師的評級反映了他們對公司業績和市場狀況的評估</p>

<p>Fortrea Holdings (NASDAQ: FTRE) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<div class="lb-trans"><p>Fortrea Holdings（納斯達克股票代碼：FTRE）在過去三個月內被 7 位分析師進行了分析，顯示出從看漲到看跌的多樣化觀點。</p>
</div><p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<div class="lb-trans"><p>下表提供了他們最近評級的簡要概覽，展示了過去 30 天情緒的變化，並與前幾個月進行了比較。</p>
</div><table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th align="right"><strong>看漲</strong></th>
<th align="right"><strong>稍微看漲</strong></th>
<th align="right"><strong>無所謂</strong></th>
<th align="right"><strong>稍微看跌</strong></th>
<th align="right"><strong>看跌</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>總評級</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>過去 30 天</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1 個月前</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2 個月前</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3 個月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
</div><p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $17.29, along with a high estimate of $25.00 and a low estimate of $10.00. Surpassing the previous average price target of $10.57, the current average has increased by 63.58%.</p>
<div class="lb-trans"><p>分析師們提供了更深入的見解，設定了 12 個月的價格目標，顯示出平均目標為 17.29 美元，最高預估為 25.00 美元，最低預估為 10.00 美元。當前平均價格目標超過了之前的 10.57 美元，增長了 63.58%。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769112083_0.png" alt="price target chart" original-src="https://www.benzinga.com/files/images/story/2026/1769112083_0.png"/></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<div class="lb-trans"><h2>分析師評級調查：詳盡研究</h2>
</div><p>A clear picture of Fortrea Holdings's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<div class="lb-trans"><p>通過對最近分析師行動的全面分析，清晰描繪了 Fortrea Holdings 在金融專家中的認知。以下總結了主要分析師、他們的最新評估以及對評級和價格目標的調整。</p>
</div><table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Charles Rhyee</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$15.00</td>
<td>$7.00</td>
</tr>
<tr>
<td>Jailendra Singh</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$22.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Elizabeth Anderson</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$25.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Ann Hynes</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$15.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Patrick Donnelly</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$21.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$10.00</td>
<td>$8.00</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>分析師</th>
<th>分析師公司</th>
<th>採取的行動</th>
<th>評級</th>
<th>當前價格目標</th>
<th>之前價格目標</th>
</tr>
</thead>
<tbody>
<tr>
<td>Charles Rhyee</td>
<td>TD Cowen</td>
<td>上調</td>
<td>持有</td>
<td>$15.00</td>
<td>$7.00</td>
</tr>
<tr>
<td>Jailendra Singh</td>
<td>Truist Securities</td>
<td>上調</td>
<td>買入</td>
<td>$22.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Elizabeth Anderson</td>
<td>Evercore ISI Group</td>
<td>上調</td>
<td>超越大盤</td>
<td>$25.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Ann Hynes</td>
<td>Mizuho</td>
<td>上調</td>
<td>中立</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>上調</td>
<td>等權重</td>
<td>$15.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Patrick Donnelly</td>
<td>Citigroup</td>
<td>上調</td>
<td>買入</td>
<td>$21.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>上調</td>
<td>低於權重</td>
<td>$10.00</td>
<td>$8.00</td>
</tr>
</tbody>
</table>
</div><h3>Key Insights:</h3>
<div class="lb-trans"><h3>關鍵見解：</h3>
</div><ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Fortrea Holdings. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Fortrea Holdings compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for Fortrea Holdings's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>採取的行動：</strong> 分析師根據市場條件和公司表現調整他們的建議。無論是 ‘維持’、‘上調’ 還是 ‘下調’ 他們的立場，反映了他們對 Fortrea Holdings 近期發展的反應。這些信息提供了分析師對公司當前狀態的看法快照。</li>
<li><strong>評級：</strong> 分析師提供了全面的分析，給出定性評估，從 ‘超越大盤’ 到 ‘低於大盤’。這些評級反映了對 Fortrea Holdings 相對於更廣泛市場表現的預期。</li>
<li><strong>價格目標：</strong> 理解預測，分析師提供了對 Fortrea Holdings 未來價值的估計。檢查當前和之前的目標提供了分析師預期變化的見解。</li>
</ul>
</div><p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Fortrea Holdings's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<div class="lb-trans"><p>將這些分析師評估與其他財務指標結合考慮，可以提供對 Fortrea Holdings 市場地位的全面理解。保持信息靈通，做出明智的決策，參考我們的評級表。</p>
</div><p>Stay up to date on Fortrea Holdings analyst ratings.</p>
<div class="lb-trans"><p>隨時瞭解 Fortrea Holdings 的分析師評級。</p>
</div><p>If you are interested in following small-cap stock news and performance you can start by tracking it here.</p>
<div class="lb-trans"><p>如果您對跟蹤小型股新聞和表現感興趣，您可以從這裏開始跟蹤。</p>
</div><h2>About Fortrea Holdings</h2>
<div class="lb-trans"><h2>關於 Fortrea Holdings</h2>
</div><p>Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.</p>
<div class="lb-trans"><p>Fortrea 是一家全球性的晚期合同研究組織，提供從第一階段到第四階段的臨牀試驗管理、臨牀藥理學和患者接入解決方案。該公司與新興和大型生物製藥、醫療設備和診斷公司合作，作為功能服務提供商、全方位服務提供商進行臨牀試驗，並提供混合試驗。2023 年，Fortrea 作為一家獨立的上市公司成立，此前 Labcorp 將其臨牀開發業務剝離，該業務是通過 2015 年以 61 億美元收購 Covance 而獲得的。Fortrea 在 90 個國家擁有 19,000 名員工。</p>
</div><h3>Fortrea Holdings's Economic Impact: An Analysis</h3>
<div class="lb-trans"><h3>Fortrea Holdings 的經濟影響：分析</h3>
</div><p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<div class="lb-trans"><p><strong>市值分析：</strong> 該公司的市值低於行業平均水平，表明其相對於同行較小。這可能由於多種因素，包括被認為的增長潛力或運營規模。</p>
</div><p><strong>Revenue Growth:</strong> Over the 3M period, Fortrea Holdings showcased positive performance, achieving a revenue growth rate of <strong>3.91%</strong> as of 30 September, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<div class="lb-trans"><p><strong>收入增長：</strong> 在過去的 3 個月中，Fortrea Holdings 表現積極，截至 2025 年 9 月 30 日，其收入增長率為 <strong>3.91%</strong>。這反映了公司營業收入的顯著增加。與醫療保健行業的其他公司相比，該公司面臨挑戰，增長率低於同行的平均水平。</p>
</div><p><strong>Net Margin:</strong> Fortrea Holdings's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>-2.27%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<div class="lb-trans"><p><strong>淨利潤率：</strong> Fortrea Holdings 的淨利潤率超過行業標準，突顯了公司的卓越財務表現。其淨利潤率為 <strong>-2.27%</strong>，公司有效管理成本，實現了強勁的盈利能力。</p>
</div><p><strong>Return on Equity (ROE):</strong> Fortrea Holdings's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>-2.72%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<div class="lb-trans"><p><strong>股本回報率（ROE）：</strong> Fortrea Holdings 的 ROE 低於行業平均水平，表明在有效利用股本方面面臨挑戰。其 ROE 為 <strong>-2.72%</strong>，公司可能在為股東創造最佳回報方面面臨困難。</p>
</div><p><strong>Return on Assets (ROA):</strong> Fortrea Holdings's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>-0.57%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<div class="lb-trans"><p><strong>資產回報率（ROA）：</strong> Fortrea Holdings 的 ROA 低於行業平均水平，表明在有效利用資產方面可能面臨挑戰。其 ROA 為 <strong>-0.57%</strong>，公司可能在實現最佳財務回報方面面臨困難。</p>
</div><p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>2.04</strong>, Fortrea Holdings faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<div class="lb-trans"><p><strong>債務管理：</strong> Fortrea Holdings 的債務與股本比率為 <strong>2.04</strong>，面臨有效管理債務水平的挑戰，表明潛在的財務壓力。</p>
</div><h2>Understanding the Relevance of Analyst Ratings</h2>
<div class="lb-trans"><h2>理解分析師評級的相關性</h2>
</div><p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.</p>
<div class="lb-trans"><p>分析師是銀行和金融系統中的專業人士，通常針對特定股票或定義的行業進行報告。這些人研究公司的財務報表，參加電話會議和會議，並與相關內部人士交談，以確定股票的分析師評級。通常，分析師每季度會對每隻股票進行評級。</p>
</div><p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<div class="lb-trans"><p>一些分析師會發布他們對增長預估、收益和收入等指標的預測，以提供額外的評級指導。在使用分析師評級時，重要的是要記住，股票和行業分析師也是人，他們只是向投資者提供自己的意見。</p>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自動內容引擎生成，並經過編輯審核。</p>
</div>

數字之外：7 位分析師討論 Fortrea Holdings 的股票